VEEV
Veeva Systems Inc.

Veeva Systems Inc.VEEV

Healthcare · Health Information Services
303.73USD
-2.05%
Nov 09, 2026
VEEV overview ready
Life Sciences Cloud Software Enabling Regulated Workflow Integration
Veeva is a life-sciences vertical-software pure play.
Theme not measured
Healthcare IT has no leadership state this session.
Constructive pullback in an uptrend
Longer-term context reads early trend, with a near-term setup of constructive pullback.
Demanding valuation
Veeva Systems Inc. carries a Expensive valuation stance that the scored components do not clearly support.
Unremarkable fundamentals
Primary risk
Dependence on continued adoption of cloud platforms in regulated industries.
Market Nov 6Filing Jul 31Price action Nov 8Research Jul 29

Conviction Level

Theme Momentum has no canonical measurement for this company — a research-profile dimension, not an input to this score.

PriceAction5.4BusinessPerformance7.0BusinessQuality9.2Valuation2.7ThemeMomentum—Improving — Revenue is growing at a steady pace (+18% year over year). Diluted EPS growth has strengthened to +40% year over year ($1.66), up from +15%. — From filed financial statements. Describes the recent trajectory of the business, not the stock. 20 of the 100 Conviction points.

Conviction uses Price Action, Business Performance, Business Quality, Valuation. Theme Momentum is research context, not an input.

Theme momentumPrimary theme · group context, not entry timing
Healthcare IT — Healthcare IT is tracked (3–4 priced members) — too few for a leadership state
Its economic family, Software, reads Weakening (+6.0pp vs SPY) — the family’s reading, not this theme’s.
Price
Loading price history…

Price Action

Constructive pullback in an uptrend
Longer-term context reads early trend, with a near-term setup of constructive pullback.
EntryConstructive

Structure is constructive, but price remains well extended from the long-term weekly base — a workable rather than ideal entry location.

Key Financials

Market Cap
$49.2B
Avg Volume (60D)
1.5M
60 sessions
Revenue Growth YoY
+16.3%
FY2026 vs FY2025
Gross Margin
+75.0%
Trailing twelve months
Operating Margin
+29.9%
Trailing twelve months
Free Cash Flow Yield
+2.6%
Distance from 200DMA
+43.7%
Next Earnings
2026-11-25
P/E
48.5x
Market metrics as of Nov 6, 2026
Financial results for the period ended Jul 31, 2026
Filed balance-sheet data as of Jul 31, 2026

Business Performance

Improving

Revenue is growing at a steady pace (+18% year over year). Diluted EPS growth has strengthened to +40% year over year ($1.66), up from +15%.

Latest reported: Q2 FY2027, ended Jul 31
Revenue growthGrowing
+18%
$928M in Q2 FY2027 · YoY
YoY growth, last 4 quarters
  1. +16%
  2. +16%
  3. +16%
  4. +18%
Earnings growthAccelerating
+40%
Diluted EPS $1.66 vs $1.19 a year earlier · GAAP
Diluted EPS YoY (GAAP), last 4 quarters
  1. +24%
  2. +23%
  3. +15%
  4. +40%
Operating marginExpanding
29.6%
+4.8 pp YoY · gross margin 75.0% (-0.3 pp)

Business Quality

9.2 / 10

How well the business earns on its assets, converts earnings to cash and funds itself — read from its SEC filings.

Fundamentals & Valuation

Both valuation perspectives agree this company is expensive.
Veeva Systems Inc. carries a Expensive valuation stance that the scored components do not clearly support. Treat it as unresolved.

What changed

Company Research

Thesis
Veeva is a life-sciences vertical-software pure play. Its industry cloud spans Development, Quality, Commercial, and Data Cloud products, with a current commercial migration cycle toward Vault CRM and expanding embedded AI capabilities.
Opportunity
Moderate opportunity
Biopharma and medtech spending on purpose-built cloud platforms that unify clinical development, regulatory, quality, safety, medical, and commercial workflows while maintaining auditability, controlled content, and industry-specific data governance.
Key risk
Dependence on continued adoption of cloud platforms in regulated industries.

Economic classification

Loading the economic classification…

Business & Markets

Healthcare · Health Information Services
What they do

Veeva Systems Inc. provides cloud-based software solutions tailored for the life sciences industry, enabling regulated companies to manage clinical, regulatory, quality, safety, medical, and commercial workflows across multiple global regions.

How it earns

The company primarily generates revenue through subscription-based licensing of its cloud software platforms.

Products & services
Veeva Vault CRM Suite
Veeva Medical
Veeva PromoMats
Veeva Crossix
Veeva Data Cloud including Veeva OpenData
Customers & end markets
Pharmaceutical companies
Biotechnology companies
Life sciences organizations
Market position

Leader in life sciences vertical cloud software with a comprehensive suite spanning development, quality, commercial, and data solutions.

Demand drivers
Low cyclicality

Demand is driven by regulatory and compliance needs in life sciences, which are relatively stable and less sensitive to economic cycles.

Related companies

Finding other covered companies in the same part of this story…